LKFT Lakefront Biotherapeutics NV

33.87USD30.88 EUR · AMS-1.40%Mkt Cap: 2.23B USDP/E: 2.57

Lakefront Biotherapeutics NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667, which is in a ph…